Long-Term Safety of Ixekizumab for Psoriasis: A Review of Key Findings

On the Frontlines of Psoriasis
18/02/2025

Listen "Long-Term Safety of Ixekizumab for Psoriasis: A Review of Key Findings "

Descargar episodio Ver en sitio original

Episode Synopsis



Guest: Atul A. Deodhar, MD, MRCP



Managing psoriasis, psoriatic arthritis, and axial spondyloarthritis with ixekizumab may cause adverse effects in patients. That’s why a recent research review further investigated the safety of this treatment over time, analyzing data from 25 clinical trials and noting common side effects. Learn more about ixekizumab’s long-term use with Dr. Atul Deodhar, the lead author of this study. He’s also a Professor of Medicine and the Medical Director of Rheumatology Clinics at Oregon Health & Science University.

More episodes of the podcast On the Frontlines of Psoriasis

Genetics in Psoriasis: Impacts on Risk, Comorbidities, and Care 23/07/2025
Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection 10/06/2025
Comparing Home and Office-Based UVB Phototherapy: Insights from the LITE Study 03/06/2025
Examining Psoriasis Prevalence: Diagnostic Differences Across Demographics 14/05/2025
Looking Beyond the Skin: The Far-Reaching Impacts of Psoriasis 21/04/2025
Scalp Psoriasis Care: When Should Systemic Therapy Be Considered? 21/04/2025
Future Directions in Psoriasis Treatment: Innovations and Implications 21/04/2025
Examining the Mediterranean Diet’s Potential in Psoriasis Management 01/04/2025
Psoriasis and Mortality: New Data on Life Expectancy 20/02/2025
Scalp Psoriasis Treatment: Examining Deucravacitinib’s Efficacy and Safety 19/02/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA